首页 >
法规速递
-
Page: Handling competing interests-2025/4/1
2025-04-02查看详情 > -
Recommendations to Reduce the Risk of Transmission of Mycobacterium tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Draft Guidance for Industry-2025/5/2
2025-05-12查看详情 > -
Document: Superseded assessment report on Zingiber officinale Roscoe, rhizoma-2025/6/19
2025-06-20查看详情 > -
Document: HMA-EMA joint Network Data Steering Group meeting 27 June 2025-2025/7/24
2025-07-25查看详情 > -
Document: Start of procedure: Extension of marketing authorisation (25 July - 21 August 2025)-2025/9/8
2025-09-09查看详情 > -
Page: Interoperability assessment at EMA-2025/10/10
2025-10-11查看详情 > -
关于公开征求《药物研发及申报临床常见问题技术指导原则（征求意见稿）》意见的通知-2025/11/18
2025-11-19查看详情 > -
Document: Work plan for the Committee for Veterinary Medicinal Products (CVMP) Pharmacovigilance Working Party (PhVWP-V) 2026-2025/12/12
2025-12-15查看详情 > -
Document: Agenda of the CHMP meeting 26-29 January 2026-2026/1/26
2026-01-27查看详情 > -
Document: Darwin EU study: Treatment patterns and user characteristics for novel migraine medicines-2026/3/4
2026-03-05查看详情 >
